John R. Beaver, EVP & Chief Financial Officer at BIOLASE, INC (BIOL), bought 1,000 shares at $1.18 ($1K) on 2018-12-03, disclosed to the SEC on 2018-12-06.
Open-market purchase of $1k BIOL by EVP & Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| BIOL | BUY | 2021-05-19 | $30K | — | Filing → |
| BIOL | BUY | 2018-08-17 | $42K | — | Filing → |